COVID-19 Update | July 10, 2020

COVID-19 News

COVID-19 Update | July 10, 2020

July 10, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of July 10, 2020. Notable advancements include:

  • Pfizer CEO Albert Bourla said this week that he believes that the Food and Drug Administration’s approval for the company’s coronavirus vaccine could come as soon as October.
  • Regeneron Pharmaceuticals Inc. will be starting its later-stage studies of its experimental COVID-19 drug to determine whether the drug is feasible for treatment and prevention.
  • Gilead has launched a Phase 1B trial to evaluate the safety of the inhaled version of remdesivir to treat COVID-19 earlier and avoid hospitalization.

​Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new CABiotech.org

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or patty.cooper@cabiotech.org.